AlloMEM

Uniquely Developed Platforms

Viscus Biologics supports our product teams and users from the early stages of innovation and platform development through healing.  We research, develop and manufacturer medical devices, specializing in allograft and xenograft platforms unique in size, strength and biologic components.  The product line shown below is currently available at market under our label or your private label or transfer of manufacturing.

allomem image

AlloMEM – Human peritoneal tissue

  • Freeze dried irradiated allograft peritoneal membrane approved  for homologous tissue wound covering
  • Pilot Study Evaluating the Efficacy of AlloMEM After Loop Ileostomy  completed at University Hospital Cleveland (Dr. Conor Delaney, 2012)
  • Regulated under 361 HCT/P as minimally manipulated human tissue
  • Approved and launched
  • Available for partnering in select indications